Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... is a hypnotic which acts at the GABA A receptor and is indicated for short-term insomnia. Sleep related disorders including somnambulism, sleep related eating and sleep-driving ...
2009 NOV 29 ... Nature, could present a new approach to treating the memory and learning deficits of insomnia. A molecular mechanism by which brief sleep deprivation alters hippocampal function is ...
2009 NOV 23 ... as a serotonin antagonist reuptake inhibitor (SARI), have a low incidence of anxiety, insomnia and sexual dysfunction." The efficacy and safety profile of Labopharm's ...
2009 NOV 23 ... and US Army hospitals to aid in the treatment of Post-Traumatic Stress Disorder (PTSD), insomnia, high stress and compassion fatigue. In honor of Veterans Day, and in light ...
2009 NOV 16 ... at 5.5 percent, pharyngitis and nasopharyngitis each at 4 percent, and dizziness and insomnia each at 3 percent. The hypoglycemic event rates were 1.0 percent for the ACTOplus met ...
2009 NOV 23 ... (81%) and insert gTSE (69%), while they were negative in most cases of fatal familial insomnia (13%) and Gerstmann-Straussler-Scheinker syndrome (10%)," wrote A. Ladogana and ...
2009 NOV 24 ... different Brazilian regions, as well as between metropolitan areas and smaller cities. Insomnia and nightmares were significantly more prevalent in women (40% and 25%, respectively), ...
2009 NOV 16 ... Polar and Non-polar Spray Containing Zolpidem," which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray ...
2009 NOV 23 ... physical functioning, nausea and vomiting, and appetite loss, whereas among BCS, insomnia and distress over hair loss were meaningfully correlated with EWB. Compared with general ...
2009 NOV 16 ... cases, and the 40,210 persons without reflux symptoms constituted the controls. Data on insomnia, sleep problems, and several potential confounders were collected in questionnaires. ...
2009 NOV 16 ... from Nigeria, "Nightmare is a common sleep disorder. While a sleep disorder such as insomnia can readily be associated with psychiatric disorders, the same cannot be said of ...
2009 NOV 16 ... up through 12 weeks of treatment were fatigue, nausea, flu-like illness, headache and insomnia. No increase in skin adverse events (rash or pruritus) beyond what was seen in the ...
2009 NOV 16 ... reported by patients who received Daytrana in clinical trials were decreased appetite, insomnia, nausea, vomiting, decreased weight, tics, affect lability, and anorexia, consistent ...
2009 NOV 16 ... sleep aid approved for the treatment of the most commonly reported nighttime symptoms of insomnia: waking frequently during the night (sleep maintenance) and waking too early and being ...
2009 NOV 16 ... company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to ...
2009 NOV 23 ... The NDA seeks approval to market Intermezzo=AE for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. ...
2009 NOV 16 ... due to the completion of the Phase III clinical trial of tasimelteon in chronic primary insomnia in 2008. As of September 30, 2009, Vanda's cash, cash equivalents, and ...
